British Biopharma Biz Raises £16M To Fund Research
British biopharmaceutical company Avacta said Monday that it has raised approximately £16 million ($21.5 million) through an equity offering to fund its research and development activities next year....To view the full article, register now.
Already a subscriber? Click here to view full article